# A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

> **NCT02307474** · NA · WITHDRAWN · sponsor: **Case Comprehensive Cancer Center**

## Conditions studied

- Clear Cell Renal Cell Carcinoma
- Renal Cell Carcinoma

## Interventions

- **RADIATION:** Stereotactic Radiosurgery
- **DRUG:** Pazopanib Hydrochloride

## Key facts

- **NCT ID:** NCT02307474
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding Unavailable
- **Last updated:** 2016-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307474, "A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02307474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*